Position in PHAT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$342,805
-$2,714,233 QoQ
Shares Held
31,595
-88.5% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 161 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. PHAT ranks #172 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | 290,713 | $38,586,336 | |||
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in PHAT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $342,805 | 31,595 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,057,038 | 275,161 | Shares | Defined | 2026-05-15 | |
| 2023-09-30 | $195,111 | 18,815 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $137,961 | 12,296 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $381,218 | 34,406 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $134,001 | 15,877 | Shares | Defined | 2022-08-15 | |
| 2021-03-31 | $420,146 | 11,186 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $949,195 | 28,573 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||